clinical trial · NCT03409588
Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty
University of Colorado, Denver·phase2·completed·n = 10
Chronic Thromboembolic Disease (CTED)Exercise Intolerance Post PEA SurgeryAdempas
brief summary
This is an open label study of Riociguat in patients with continued exercise intolerance at least 6 months following pulmonary endarterectomy (PEA).
started
Jun 13, 2018
primary completion
Jan 26, 2026
completion
Jan 26, 2026
last updated
Feb 5, 2026
official title
Treatment of Exercise-Induced Pulmonary Vascular Dysfunction in Symptomatic Patients After Pulmonary Thromboendarterectomy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol